Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

NIMICRY

Financiado

Poor Prognosis Colorectal Cancers Display Self-sustained Growth by Niche-mimicry

Colorectal cancer (CRC) is a heterogeneous disease with widely variable clinical outcomes. I previously contributed to a unifying molecular classification of CRC, the consensus molecular subtypes (CMSs). The mesenchymal subtype (C... ver más

30/09/2027

STICHTING AMSTERDA...

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

STICHTING AMSTERDAM UMC No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-09-21

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2021-COG: ERC CONSOLIDATOR GRANTS

I+D

Cerrada hace 3 años

0% 100%

1 Participantes

STICHTING AMSTERDAM UMC

1.95M€ | Lider

Proyectos interesantes

SAF2012-40017-C02-01 DYNAMICS OF THE BALANCE BETWEEN SELF-RENEWAL AND EPITHELIAL-... 176K€ Cerrado

METMAP Extracellular Vesicles as mediators of Pre-Metastatic Niche... 176K€ Cerrado

SAF2015-71606-R MECANISMOS DE METASTASIS EN MODELOS AUTOCTONOS DE CANCER DE... 157K€ Cerrado

SAF2009-11757 CARACTERIZACION DE GENES ESTROMALES PROMOTORES DE LA PROGRES... 36K€ Cerrado

BFU2011-22943 ESTUDIO DE LOS PERFILES GENETICOS Y DE MICRORNA EN LAS METAS... 68K€ Cerrado

SAF2014-53784-R ANALISIS GENETICO DEL NICHO METASTASICO EN CANCER COLORECTAL 484K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 60 meses Fecha Inicio: 2022-09-21
Fecha Fin: 2027-09-30

Líder del proyecto

STICHTING AMSTERDAM UMC

TRL 4-5

Presupuesto del proyecto 2M€

Descripción del proyecto Colorectal cancer (CRC) is a heterogeneous disease with widely variable clinical outcomes. I previously contributed to a unifying molecular classification of CRC, the consensus molecular subtypes (CMSs). The mesenchymal subtype (CMS4), representing ~25% of all CRC patients, is characterised by early metastatic dissemination and poor response to therapy. This is often attributed to activated and rich stroma and therefore much attention in the field goes to dissecting the interaction of the mesenchyme with the cancer cells in these tumours. However, in this research program I will investigate a radically different hypothesis: Mesenchymal CRCs display self-sustained growth by niche-mimicry (nimicry). I define nimicry as the adoption of niche features by cancer cells, thereby rendering the cancers independent of micro-environmental signals for their expansion. This hypothesis is directly based on preliminary experiments from my laboratory, which demonstrated that mesenchymal CRCs are not dependent on external growth factors for expansion in vitro and display autocrine and paracrine loops that drive self-sustained growth. The abundant stroma in mesenchymal CRCs is secondary to the growth factors and cytokines produced by the tumour cells. To study this concept, I will employ primary human CRC models in combination with molecular and functional characterisation, to delineate the self-supporting signalling loops in a patient specific fashion. These studies are paralleled by the investigation of clonal dynamics within established human CRCs by means of a novel genetic lineage tracing strategy in combination with quantitative analysis. Dedicated analyses will resolve the impact of nimicry on metastasis formation, therapy resistance and tumour evolution. These studies into nimicry as a critical concept in tumour biology, will importantly advance our understanding of the signals that drive CRC growth and progression, and will pave the way to new treatment strategies.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores